What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
These are not established contraindications in UK SmPCs for currently licensed GLP-1-based medicines (the human risk is unknown), but they are commonly applied as precautionary exclusion criteria in trials based on nonclinical data
One reason is that it isnt always obvious what snake bit the victim, with many regions having multiple venomous snake species present
It's the kind of thing that just quietly does its job without any fuss
PMC 3441926
Protection from the virus is essential for those at risk of developing flu-related complications, including: Infants Children under 5 years old Adults 65 and older Pregnant women Seniors living in nursing homes Other health conditions and genetic factors that may put individuals in a high-risk category are: Asthma Heart Disease Diabetes Cancer HIV/AIDS Kidney Disease Obesity People with disabilities Certain Ethnic Minorities The rare population that should not receive a flu shot includes children younger than 6 months or anyone with a severe, life-threatening allergy to an ingredient in the vaccine
